NCT00459056
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
See it on ClinicalTrials.gov ↗25 people
52%
48%
13 womenmiddle line = equal numbers12 men
- Phase
- PHASE3
- Paid for by
- St. Paul Heart Clinic
- Finished
- 2010-05
- Health conditions
- Abdominal Obesity, Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 54.0 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Women who are currently pregnant or planning to become pregnant (pregnancy testing will occur at specific intervals throughout study and women will be informed of potential risks during the consenting process; information specific to this r…”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Breastfeeding women”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Clinically significant liver disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Unstable angina”
Study titles and rules are shown in their original English.